Jun Yin

Jun Yin

Caris Life Sciences - / United States
Others
AD Scientific Index ID: 4980410
person_outline Jun Yin's MOST POPULAR ARTICLES
1-) BRD4 inhibition is synthetic lethal with PARP inhibitors through the induction of homologous recombination deficiency C Sun, J Yin, Y Fang, J Chen, KJ Jeong, X Chen, CP Vellano, Z Ju, ... Cancer cell 33 (3), 401-416. e8, 2018 2012018
2-) Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in RAS mutant cancers C Sun, Y Fang, J Yin, J Chen, Z Ju, D Zhang, X Chen, CP Vellano, ... Science translational medicine 9 (392), eaal5148, 2017 1702017
3-) Proteome instability is a therapeutic vulnerability in mismatch repair-deficient cancer DJ McGrail, J Garnett, J Yin, H Dai, DJH Shih, TNA Lam, Y Li, C Sun, Y Li, ... Cancer cell 37 (3), 371-386. e12, 2020 572020
4-) Improved prediction of PARP inhibitor response and identification of synergizing agents through use of a novel gene expression signature generation algorithmDJ McGrail, CCJ Lin, J Garnett, Q Liu, W Mo, H Dai, Y Lu, Q Yu, Z Ju, J Yin, ...NPJ systems biology and applications 3 (1), 8, 2017602017
5-) PARP inhibitors synergize with gemcitabine by potentiating DNA damage in non‐small‐cell lung cancerY Jiang, H Dai, Y Li, J Yin, S Guo, SY Lin, DJ McGrailInternational journal of cancer 144 (5), 1092-1103, 2019482019